Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

NCT00003704

Conditions
Adnexal Diseases, Anus Diseases, Anus Neoplasms, +56 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
View all 18 locations
View Trial Details
Completed

Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)

NCT00072046

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Huntsville Hospital Huntsville, Alabama, United States
  • CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
View all 493 locations
View Trial Details
Completed

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

NCT00948961

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Malignancies, +53 more
Locations
  • Yale Comprehensive Cancer Center New Haven, Connecticut, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma

NCT01491672

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Novartis Investigative Site San Miguel de Tucumán, Tucumán Province, Argentina
  • Novartis Investigative Site Rio Negro, Viedma, Argentina
  • Novartis Investigative Site Florianópolis, Santa Catarina, Brazil
View all 17 locations
View Trial Details

Related conditions